SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    D. Max Crowley, Damon E. Jones, Donna L. Coffman, Mark T. Greenberg, Can we build an efficient response to the prescription drug abuse epidemic? Assessing the cost effectiveness of universal prevention in the PROSPER trial, Preventive Medicine, 2014, 62, 71

    CrossRef

  2. 2
    Andrea Meier, Chantal Lambert-Harris, Mark P. McGovern, Haiyi Xie, Melissa An, Bethany McLeman, Co-occurring prescription opioid use problems and posttraumatic stress disorder symptom severity, The American Journal of Drug and Alcohol Abuse, 2014, 40, 4, 304

    CrossRef

  3. 3
    Margaret K. Pasquale, Ashish V. Joshi, Robert Dufour, David Schaaf, Jack Mardekian, George A. Andrews, Nick C. Patel, Cost Drivers of Prescription Opioid Abuse in Commercial and Medicare Populations, Pain Practice, 2014, 14, 3
  4. 4
    Margaret C. Wardle, Daniel A. Fitzgerald, Michael Angstadt, Christine A. Rabinak, Harriet de Wit, K. Luan Phan, Effects of oxycodone on brain responses to emotional images, Psychopharmacology, 2014,

    CrossRef

  5. 5
    J. Bradford Rice, Noam Y. Kirson, Amie Shei, Alice Kate G. Cummings, Katharine Bodnar, Howard G. Birnbaum, Rami Ben-Joseph, Estimating the Costs of Opioid Abuse and Dependence from an Employer Perspective: a Retrospective Analysis Using Administrative Claims Data, Applied Health Economics and Health Policy, 2014, 12, 4, 435

    CrossRef

  6. 6
    Jan Gryczynski, Robert P. Schwartz, Shannon Gwin Mitchell, Kevin E. O’Grady, Steven J. Ondersma, Hair drug testing results and self-reported drug use among primary care patients with moderate-risk illicit drug use, Drug and Alcohol Dependence, 2014, 141, 44

    CrossRef

  7. 7
    Margaret M. Eichel, Tonya R. Johannemann, Implementation of Universal Maternal Drug Screening to Identify Neonatal Abstinence Syndrome Candidates, Newborn and Infant Nursing Reviews, 2014, 14, 1, 17

    CrossRef

  8. 8
    Brian C. Kelly, H. Jonathon Rendina, Mike Vuolo, Brooke E. Wells, Jeffrey T. Parsons, Influences of motivational contexts on prescription drug misuse and related drug problems, Journal of Substance Abuse Treatment, 2014,

    CrossRef

  9. 9
    Louis F. Rossiter, Noam Y. Kirson, Amie Shei, Alan G. White, Howard G. Birnbaum, Rami Ben-Joseph, Edward Michna, Medical cost savings associated with an extended-release opioid with abuse-deterrent technology in the US, Journal of Medical Economics, 2014, 17, 4, 279

    CrossRef

  10. 10
    Sherri Rauenzahn, Egidio Del Fabbro, Opioid management of pain, Current Opinion in Supportive and Palliative Care, 2014, 8, 3, 273

    CrossRef

  11. 11
    Harmony Rhoades, Suzanne L. Wenzel, Daniela Golinelli, Joan S. Tucker, David P. Kennedy, Brett Ewing, Predisposing, Enabling and Need Correlates of Mental Health Treatment Utilization Among Homeless Men, Community Mental Health Journal, 2014,

    CrossRef

  12. 12
    Jeffrey Vietri, Ashish V. Joshi, Alexandra I. Barsdorf, Jack Mardekian, Prescription Opioid Abuse and Tampering in the United States: Results of a Self-Report Survey, Pain Medicine, 2014, 15, 8
  13. 13
    Roxanne Meyer, Anisha M. Patel, Stacy K. Rattana, Tiffany P. Quock, Samir H. Mody, Prescription Opioid Abuse: A Literature Review of the Clinical and Economic Burden in the United States, Population Health Management, 2014, 140730130639004

    CrossRef

  14. 14
    Onur Baser, Lin Xie, Jack Mardekian, David Schaaf, Li Wang, Ashish V. Joshi, Prevalence of Diagnosed Opioid Abuse and its Economic Burden in the Veterans Health Administration, Pain Practice, 2014, 14, 5
  15. 15
    Joseph Tkacz, Joseph Volpicelli, Hyong Un, Charles Ruetsch, Relationship Between Buprenorphine Adherence and Health Service Utilization and Costs Among Opioid Dependent Patients, Journal of Substance Abuse Treatment, 2014, 46, 4, 456

    CrossRef

  16. 16
    Aaron M. Martin, Eric G. Benotsch, Anna Cejka, Diana Luckman, Social Responsibility, Substance Use, and Sexual Risk Behavior in Men Who Have Sex With Men, Journal of Homosexuality, 2014, 61, 2, 251

    CrossRef

  17. 17
    Noam Y. Kirson, Amie Shei, Alan G. White, Howard G. Birnbaum, Rami Ben-Joseph, Louis F. Rossiter, Edward Michna, Societal Economic Benefits Associated with an Extended-Release Opioid with Abuse-Deterrent Technology in the United States, Pain Medicine, 2014, 15, 8
  18. 18
    Robert Dufour, Ashish V. Joshi, Margaret K. Pasquale, David Schaaf, Jack Mardekian, George A. Andrews, Nick C. Patel, The Prevalence of Diagnosed Opioid Abuse in Commercial and Medicare Managed Care Populations, Pain Practice, 2014, 14, 3
  19. 19
    Tess K. Drazdowski, Lena Jäggi, Alicia Borre, Wendy L. Kliewer, Use of prescription drugs and future delinquency among adolescent offenders, Journal of Substance Abuse Treatment, 2014,

    CrossRef

  20. 20
    G.J. Brenner, R.S. Griffin, Encyclopedia of the Neurological Sciences, 2014,

    CrossRef

  21. You have free access to this content21
    Kenneth W. Kizer, Advancing Pain Care—Core Competencies for Pain Management, Pain Medicine, 2013, 14, 7
  22. 22
    Richard C Crist, Toni-Kim Clarke, Alfonso Ang, Lisa M Ambrose-Lanci, Falk W Lohoff, Andrew J Saxon, Walter Ling, Maureen P Hillhouse, R Douglas Bruce, George Woody, Wade H Berrettini, An Intronic Variant in OPRD1 Predicts Treatment Outcome for Opioid Dependence in African-Americans, Neuropsychopharmacology, 2013, 38, 10, 2003

    CrossRef

  23. 23
    Beatrice Setnik, Kenneth Sommerville, Veeraindar Goli, Ling Han, Lynn Webster, Assessment of Pharmacodynamic Effects Following Oral Administration of Crushed Morphine Sulfate and Naltrexone Hydrochloride Extended-Release Capsules Compared with Crushed Morphine Sulfate Controlled-Release Tablets and Placebo in Nondependent Recreational Opioid Users, Pain Medicine, 2013, 14, 8
  24. 24
    Kelly E. Dunn, Kathryn A. Saulsgiver, Mollie E. Patrick, Sarah H. Heil, Stephen T. Higgins, Stacey C. Sigmon, Characterizing and improving HIV and hepatitis knowledge among primary prescription opioid abusers, Drug and Alcohol Dependence, 2013, 133, 2, 625

    CrossRef

  25. 25
    Hitesh S. Chandwani, Scott A. Strassels, Karen L. Rascati, Kenneth A. Lawson, James P. Wilson, Estimates of Charges Associated With Emergency Department and Hospital Inpatient Care for Opioid Abuse-Related Events, Journal of Pain and Palliative Care Pharmacotherapy, 2013, 130723120816005

    CrossRef

  26. 26
    Yahiya Y. Syed, Gillian M. Keating, Extended-Release Intramuscular Naltrexone (VIVITROL®): A Review of Its Use in the Prevention of Relapse to Opioid Dependence in Detoxified Patients, CNS Drugs, 2013, 27, 10, 851

    CrossRef

  27. 27
    R. Kathryn McHugh, Elise E. DeVito, Dorian Dodd, Kathleen M. Carroll, Jennifer Sharpe Potter, Shelly F. Greenfield, Hilary Smith Connery, Roger D. Weiss, Gender differences in a clinical trial for prescription opioid dependence, Journal of Substance Abuse Treatment, 2013, 45, 1, 38

    CrossRef

  28. 28
    Laxmaiah Manchikanti, Mark V Boswell, Joshua A Hirsch, Lessons learned in the abuse of pain-relief medication: a focus on healthcare costs, Expert Review of Neurotherapeutics, 2013, 13, 5, 527

    CrossRef

  29. 29
    C. Richard Chapman, Opioid Pharmacotherapy for Chronic Noncancer Pain: The American Experience, The Korean Journal of Pain, 2013, 26, 1, 3

    CrossRef

  30. 30
    Yan Xu, Ana Johnson, Opioid Therapy Pharmacogenomics for Noncancer Pain: Efficacy, Adverse Events, and Costs, Pain Research and Treatment, 2013, 2013, 1

    CrossRef

  31. 31
    Marc L. Fleming, Hitesh Chandwani, Jamie C. Barner, Stephanie N. Weber, Tony T. Okoro, Prescribers and Pharmacists Requests for Prescription Monitoring Program (PMP) Data: Does PMP Structure Matter?, Journal of Pain and Palliative Care Pharmacotherapy, 2013, 27, 2, 136

    CrossRef

  32. 32
    Janice Phillips, Prescription drug abuse: Problem, policies, and implications, Nursing Outlook, 2013, 61, 2, 78

    CrossRef

  33. 33
    Carlos Blanco, Miren Iza, Robert P. Schwartz, Claudia Rafful, Shuai Wang, Mark Olfson, Probability and predictors of treatment-seeking for prescription opioid use disorders: A National Study, Drug and Alcohol Dependence, 2013, 131, 1-2, 143

    CrossRef

  34. You have free access to this content34
    Alex Cahana, Elizabeth J. Dansie, Brian R. Theodore, Hilary D. Wilson, Dennis C. Turk, Redesigning Delivery of Opioids to Optimize Pain Management, Improve Outcomes, and Contain Costs, Pain Medicine, 2013, 14, 1
  35. 35
    John M. Stogner, Chris L. Gibson, Stressful life events and adolescent drug use: Moderating influences of the MAOA gene, Journal of Criminal Justice, 2013, 41, 5, 357

    CrossRef

  36. 36
    Timothy J. Inocencio, Norman V. Carroll, Edward J. Read, David A. Holdford, The Economic Burden of Opioid-Related Poisoning in the United States, Pain Medicine, 2013, 14, 10
  37. 37
    Erik Kvamme, Mary Catlin, Caleb Banta-Green, John Roll, Roger Rosenblatt, Who prescribes buprenorphine for rural patients? The impact of specialty, location and practice type in Washington State, Journal of Substance Abuse Treatment, 2013, 44, 3, 355

    CrossRef

  38. 38
    J. Bradford Rice, Alan G. White, Howard G. Birnbaum, Matt Schiller, David A. Brown, Carl L. Roland, A Model to Identify Patients at Risk for Prescription Opioid Abuse, Dependence, and Misuse, Pain Medicine, 2012, 13, 9
  39. 39
    Suzanne K. Vosburg, Jermaine D. Jones, Jeanne M. Manubay, Judy B. Ashworth, Irma H. Benedek, Sandra D. Comer, Assessment of a formulation designed to be crush-resistant in prescription opioid abusers, Drug and Alcohol Dependence, 2012, 126, 1-2, 206

    CrossRef

  40. 40
    Joseph Tkacz, Jamie Severt, Cheryl Kassed, Charles Ruetsch, Clinical Differences Between Opioid Abuse Classes Ameliorated After 1 Year of Buprenorphine-Medication Assisted Treatment, Journal of Addictive Diseases, 2012, 31, 2, 100

    CrossRef

  41. 41
    V. Pauly, V. Pradel, L. Pourcel, S. Nordmann, E. Frauger, M. Lapeyre-Mestre, J. Micallef, X. Thirion, Estimated magnitude of diversion and abuse of opioids relative to benzodiazepines in France, Drug and Alcohol Dependence, 2012, 126, 1-2, 13

    CrossRef

  42. 42
    Linda Simoni-Wastila, Jingjing Qian, Influence of prescription monitoring programs on analgesic utilization by an insured retiree population, Pharmacoepidemiology and Drug Safety, 2012, 21, 12
  43. 43
    Evgeny Krupitsky, Injectable extended-release naltrexone for the prevention of relapse to opioid dependence following opioid detoxification, Neuropsychiatry, 2012, 2, 4, 355

    CrossRef

  44. 44
    James P. Zacny, Judith A. Paice, Dennis W. Coalson, Separate and combined psychopharmacological effects of alprazolam and oxycodone in healthy volunteers, Drug and Alcohol Dependence, 2012, 124, 3, 274

    CrossRef

  45. 45
    Angela M. Williams, Daniel J. Reis, Alexa S. Powell, Louis J. Neira, Kathryn A. Nealey, Cole E. Ziegler, Nina D. Kloss, Jessica L. Bilimoria, Chelsea E. Smith, Brendan M. Walker, The effect of intermittent alcohol vapor or pulsatile heroin on somatic and negative affective indices during spontaneous withdrawal in Wistar rats, Psychopharmacology, 2012, 223, 1, 75

    CrossRef

  46. 46
    John J. Coleman, The Supply Chain of Medicinal Controlled Substances: Addressing the Achilles Heel of Drug Diversion, Journal of Pain and Palliative Care Pharmacotherapy, 2012, 26, 3, 233

    CrossRef

  47. 47
    Summer J. McGee, Brett D. Kaylor, Helen Emmott, Myra J. Christopher, Defining Chronic Pain Ethics, Pain Medicine, 2011, 12, 9